APA (7th ed.) Citation

Joarder, R., Patel, D., Tiwari, A., Choudhary, J., Vana, P., Shenoy, V., . . . Ostwal, V. TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd.

Chicago Style (17th ed.) Citation

Joarder, Ritam, et al. TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd.

MLA (9th ed.) Citation

Joarder, Ritam, et al. TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd.